Clinical Trial Update: 24-hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating 24-hour intraocular pressure control with the bimatoprost/timolol fixed combination in glaucoma has been completed. The update indicate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Ganfort (bimatoprost; timolol)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Glaucoma | Phase 4 | Status: COMPLETED